Could a custom chemo dose reduce side effects in lymphoma treatment?
NCT ID NCT05540340
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 26 times
Summary
This study tests a new way to calculate the dose of the chemotherapy drug melphalan for people with lymphoma who are about to have a stem cell transplant. Instead of using a standard dose based on height and weight, researchers use a model that considers how previous patients processed the drug, aiming to give each person the right amount to be effective but with fewer side effects. The study includes 39 adults aged 18-79 with various lymphoma types who are already scheduled for this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.